TheEdgeResearch
Home / Stocks / TPVG

TriplePoint Venture Growth BDC Corp. (TPVG)

NYSE Financial Services Asset Management
$5.40 ▲ +2.27%
Market Cap
$219.2M
Sector
Financial Services
Industry
Asset Management
Beta
1.35
52-Wk Range
4.395-6.95
CEO
James Peter Labe
Country
US
Currency
USD

TriplePoint Venture Growth BDC Corp. operates in the Asset Management industry of the Financial Services sector, headquartered in Menlo Park, CA, US. The stock last traded at $5.40, up 2.27% on the session, giving a market capitalisation of $219.2M. On trailing twelve-month figures it carries a trailing P/E of 5.45, a net margin of 46.0%. Its beta of 1.35 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
5.45
Price / Sales
2.60
Price / Book
0.62
EV / EBITDA
11.75
Gross margin
76.0%
Operating margin
65.6%
Net margin
46.0%
Return on equity
Debt / equity
1.26
Current ratio
0.12
Dividend yield
17.4%
Payout ratio
93.0%
Company profile
Exchange
New York Stock Exchange
Employees
0
IPO date
2014-03-06
Headquarters
Menlo Park, CA, US
About TriplePoint Venture Growth BDC Corp.

TriplePoint Venture Growth BDC Corp. (TPVG) functions as a business development company, primarily concentrating its investments on growth-stage enterprises backed by venture capital. The firm's core offering involves providing debt financing solutions to companies within the venture growth ecosystem. These solutions encompass a diverse range of products, such as growth capital loans, customized and secured credit facilities, equipment financing, and revolving lines of credit. Additionally, TPVG engages in direct equity investments. Its investment strategy targets companies operating in key sectors, including e-commerce, entertainment, technology, and life sciences. Within the technology sphere, the areas of specific interest are broad, covering cybersecurity, wireless communication equipment, network systems and software, business application software, conferencing solutions, big data analytics, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, various software categories (including Software-as-a-Service), and other related technological subsectors. For life sciences, TPVG focuses on biotechnology, biofuels/biomass, diagnostic testing and bioinformatics, drug delivery systems, drug discovery, healthcare information systems, healthcare services, medical/surgical/therapeutic devices, pharmaceuticals, and other related fields. The size of TPVG's investments varies based on the type of financing: growth capital loans typically range from $5 million to $50 million, equipment financings are between $5 million and $25 million, and revolving loans generally fall between $1 million and $25 million. Direct equity investments, conversely, are usually from $0.1 million to $5 million, and are structured to not exceed 5% of the portfolio company's total equity. The debt financing instruments are commonly structured as lines of credit, and the company also employs warrants and secured loans in its funding approach. TPVG aims to achieve targeted returns of 10% to 18%. A distinctive aspect of its investment policy is that it does not seek board representation in the companies it finances.

Comparable companies

TriplePoint Venture Growth BDC Corp. is most often compared with the following Financial Services names:

BLZRUGIWWULIENMFINMLCIMPVNEWTSSSSSWKHTONX
More research on TPVG
TPVG technical analysis TPVG TheEdge Score Compare against peers
Open full interactive analysis & DCF →